Aptorum Group Ltd — Investor Relations & Filings
Aptorum Group Ltd. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to address unmet medical needs. The company's research and development pipeline targets a range of therapeutic areas, including orphan oncology, infectious diseases, and metabolic diseases. Key projects include SACT-1, a repurposed drug candidate for neuroblastoma, and ALS-4, an anti-virulence, non-bactericidal therapeutic for infections caused by Staphylococcus aureus. Additionally, the company is developing its RPIDD (Rapid Pathogen Identification and Detection Diagnostics) platform, a liquid biopsy-based technology for rapidly identifying and detecting pathogens.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| AMENDMENT NO. 1 TO FORM 6-K | 2024-10-25 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2024-08-09 | English | |
| REGISTRATION STATEMENT | 2024-07-26 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2024-05-31 | English | |
| ANNUAL REPORT | 2024-04-30 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2024-04-30 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
9 filings
| |||||
| 13097407 | AMENDMENT NO. 1 TO FORM 6-K | 2024-10-25 | English | ||
| 13097406 | REPORT OF FOREIGN PRIVATE ISSUER | 2024-08-09 | English | ||
| 13097408 | REGISTRATION STATEMENT | 2024-07-26 | English | ||
| 13097409 | REPORT OF FOREIGN PRIVATE ISSUER | 2024-05-31 | English | ||
| 13097410 | ANNUAL REPORT | 2024-04-30 | English | ||
| 13097411 | REPORT OF FOREIGN PRIVATE ISSUER | 2024-04-30 | English | ||
| 13097412 | AMENDMENT NO. 4 TO SCHEDULE 13D | 2024-04-16 | English | ||
| 13097413 | REPORT OF FOREIGN PRIVATE ISSUER | 2024-03-06 | English | ||
| 13097414 | APM 13G/A | 2024-02-02 | English | ||
|
2023
6 filings
| |||||
| 13097415 | REPORT OF FOREIGN PRIVATE ISSUER | 2023-12-22 | English | ||
| 13097416 | REPORT OF FOREIGN PRIVATE ISSUER | 2023-12-21 | English | ||
| 13097417 | REPORT OF FOREIGN PRIVATE ISSUER | 2023-11-30 | English | ||
| 13097418 | FORM 6-K/A | 2023-11-21 | English | ||
| 13097419 | REPORT OF FOREIGN PRIVATE ISSUER | 2023-11-16 | English | ||
| 13097420 | REPORT OF FOREIGN PRIVATE ISSUER | 2023-09-11 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Aptorum Group Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35125/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35125 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35125 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35125 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35125}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Aptorum Group Ltd (id: 35125)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.